Global Leading Market Research Publisher QYResearch announces the release of its latest report “Lateral Flow Sample Pads – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Lateral Flow Sample Pads market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Lateral Flow Sample Pads was estimated to be worth US95millionin2025andisprojectedtoreachUS95millionin2025andisprojectedtoreachUS 140 million by 2032, growing at a CAGR of 5.6% from 2026 to 2032.
For lateral flow assay (LFA) manufacturers and point-of-care (POC) diagnostic developers, the core sample pad material challenge is precise: providing a porous, hydrophilic matrix (glass fiber, cellulose, polyester, or synthetic polymer) placed at the proximal end of the test strip, capable of receiving liquid sample (whole blood, serum, plasma, urine, saliva, nasal swab eluate, buffer, stool suspension, food homogenate), uniformly distributing the sample across the pad width (capillary action, lateral flow), removing particulate matter (red blood cells (RBCs), debris) and interfering substances (fibrin, mucus, bacteria, particle), controlling flow rate (slow for antigen-antibody binding, fast for wash), modulating pH, and pretreating sample with buffers or detergents (to lyse cells, neutralize inhibitors, dissociate immune complexes), ensuring consistent and reproducible migration onto the conjugate pad and nitrocellulose membrane. The solution lies in lateral flow sample pads—non-woven or woven fiber matrices (glass fiber most common, cellulose, polyester, polypropylene, or cotton blends) treated with surfactants (blocking agents, detergents, bovine serum albumin (BSA), casein, and polymers) to minimize non-specific binding, optimize wicking speed, and maintain protein stability. Unlike conjugate pads (dried conjugate reservoir) and membrane (capture/control lines), sample pads serve as the sample application zone and pre-treatment/filter layer. As POC testing expands (decentralized healthcare, self-testing, pandemic preparedness), the sample pad market grows.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5984786/lateral-flow-sample-pads
1. Industry Segmentation by Fiber Type and Application
The Lateral Flow Sample Pads market is segmented as below by Type:
- Glass Fiber – 52% market share (2025). High wicking speed, high binding capacity, red blood cell separation (blood-typing). Easily treated with surfactants. Most common for infectious disease rapid tests (COVID-19, influenza, HIV, malaria, dengue, Lyme), cardiac markers (troponin, BNP), fertility/ovulation (LH), drugs-of-abuse (DOA), pregnancy (hCG).
- Synthetic Fiber (polyester, polypropylene, polyethylene) – 28% market share, fastest-growing (low non-specific binding). Increasing for veterinary, food safety.
- Cotton Fiber – 20% market share (natural, low cost, variable). For low-cost tests.
By Application – Medical (human diagnostics) leads with 72% market share. Agricultural and Animal Husbandry (veterinary rapid tests, livestock disease, poultry, aquaculture) 12% share. Food & Beverage (pathogen, allergen, mycotoxin) 8% share. Military and Forensic (drug-of-abuse, explosives) 5% share. Others (environmental) 3% share.
Key Players – Lateral flow raw material suppliers: Cytiva (Danaher, Whatman, MilliporeSigma), Merck (MilliporeSigma), Ahlstrom (US, fiber-based materials), Axiva (India), Axiflow (Israel). Porex Corporation (porous polymers). AntiTeck (China), Advanced Microdevices (mdi) (India). Asahi Kasei (Japan). Cytodiagnostic (UK). Also: Sartorius, GVS, Lohmann.
2. Technical Challenges: Red Blood Cell Separation, Wicking Speed, and Blocking Treatment
Whole blood separation — For capillary or venous whole blood (fingerstick, venipuncture), sample pad must retain red blood cells (3-5μm diameter) while allowing plasma/serum to migrate to conjugate pad. Glass fiber matrix captures RBCs (large pores). Plasma separation membranes (asymmetric polysulfone, polyethersulfone) also used, but blood separation sample pad.
Wicking speed (flow rate) — Time for sample to travel from pad to conjugate pad (and to test line). Optimal 30 seconds to 5 minutes depending on target (antibody/antigen binding kinetics). Surfactant treatment controls hydrophilicity (contact angle).
Blocking treatment — Pre-treated with BSA, casein, PVP (polyvinylpyrrolidone), PVA (polyvinyl alcohol), Tween-20 (polysorbate 20), Triton X-100 to reduce non-specific binding (false positives). Air drying before assembly.
3. Policy, User Cases & Market Drivers (Last 6 Months, 2025-2026)
- CLSI POCT12 (2025) (Point-of-care testing) – Validation of sample pad performance (flow rate, whole blood separation).
- IVDR (EU) 2017/746 (in vitro diagnostic regulation) (2025) – Class B/C rapid tests. Quality documentation for sample pad material (lot-to-lot consistency).
- WHO prequalification (2025) – Malaria, HIV. Sample pad must meet WHO criteria (blood separation, flow rate, non-specific binding).
User Case – Home Pregnancy Test (hCG (human chorionic gonadotropin) urine) — Sample pad (cellulose/glass fiber) absorbs urine, wicks to conjugate pad (gold-α-hCG). No blood separation.
User Case – COVID-19 Antigen Rapid Test (nasal swab) — Swab eluted into extraction buffer, 3-4 drops added to sample well (pad). Pad absorbs buffer, moves to conjugate pad (gold-anti-N antibody). Not whole blood.
User Case – HIV/HCV (hepatitis C virus) rapid test (fingerstick blood) — Sample pad (glass fiber) separates RBCs from plasma, plasma migrates to conjugate pad (gp41/36 antigen-gold for HIV). Results 15-20 minutes.
4. Exclusive Observation: Dried Blood Spot (DBS) Sample Pads
Dried blood spot (DBS) cards used for remote collection (fingerprick dried on paper). Sample pad not used.
5. Outlook & Strategic Implications (2026-2032)
Through 2032, the lateral flow sample pad market will segment: glass fiber (whole blood applications, infectious disease) — 55% value, 5-6% CAGR; synthetic polymer (low non-specific binding) — 30% value, 6-7% CAGR; others (cotton) — 15% value, 4% CAGR. Key success factors: blood separation efficiency (100% RBC retention), wicking speed (mm/sec), blocking efficacy (non-specific binding <2% of positive control), and lot consistency (CV <5%). Suppliers who fail to transition from glass fiber to synthetic polymer (for lower NSB) — and who cannot provide custom blocking formulations — will lose lateral flow raw material market share.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
